z-logo
open-access-imgOpen Access
Role of oxidative stress in calcific aortic valve disease and its therapeutic implications
Author(s) -
Harry Z E Greenberg,
Guoan Zhao,
Ajay Shah,
Min Zhang
Publication year - 2021
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvab142
Subject(s) - oxidative stress , medicine , calcification , disease , myofibroblast , fibrosis , reactive oxygen species , pathophysiology , aortic valve , bioinformatics , pathology , biology , microbiology and biotechnology
Calcific aortic valve disease (CAVD) is the end result of active cellular processes that lead to the progressive fibrosis and calcification of aortic valve leaflets. In western populations, CAVD is a significant cause of cardiovascular morbidity and mortality, and in the absence of effective drugs, it will likely represent an increasing disease burden as populations age. As there are currently no pharmacological therapies available for preventing, treating, or slowing the development of CAVD, understanding the mechanisms underlying the initiation and progression of the disease is important for identifying novel therapeutic targets. Recent evidence has emerged of an important causative role for reactive oxygen species (ROS)-mediated oxidative stress in the pathophysiology of CAVD, inducing the differentiation of valve interstitial cells into myofibroblasts and then osteoblasts. In this review, we focus on the roles and sources of ROS driving CAVD and consider their potential as novel therapeutic targets for this debilitating condition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here